Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsy. - Wikidata - awgldk - TriplyDB

Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsy.

Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsy.

http://www.wikidata.org/entity/Q46632925

about

Clinical performance of serum [-2]proPSA derivatives, %p2PSA and PHI, in the detection and management of prostate cancer Comprehensive assessment for novel prostate cancer markers in the prostate-specific antigen era: focusing on Asians and Asian countries Long Non-coding RNAs in Urologic Malignancies: Functional Roles and Clinical Translation Evolving transcriptomic fingerprint based on genome-wide data as prognostic tools in prostate cancer Current early diagnostic biomarkers of prostate cancer Prevention and early detection of prostate cancer.Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2-10 ng/ml External validation of extended prostate biopsy nomogram.RNA biomarkers to facilitate the identification of aggressive prostate cancer Evaluation of prostate cancer antigen 3 for detecting prostate cancer: a systematic review and meta-analysis.Performance of the Prostate Health Index in predicting prostate biopsy outcomes among men with a negative digital rectal examination and transrectal ultrasonography Diagnostic ability of %p2PSA and prostate health index for aggressive prostate cancer: a meta-analysis.PCA3 in the detection and management of early prostate cancer.The role of biomarkers in the assessment of prostate cancer risk prior to prostate biopsy: which markers matter and how should they be used?Next-generation prostate-specific antigen test: precursor form of prostate-specific antigen.Guidance on patient consultation. Current evidence for prostate-specific antigen screening in healthy men and treatment options for men with proven localised prostate cancer.Blood-based and urinary prostate cancer biomarkers: a review and comparison of novel biomarkers for detection and treatment decisions.Comparative evaluation of urinary PCA3 and TMPRSS2: ERG scores and serum PHI in predicting prostate cancer aggressiveness.Improving multivariable prostate cancer risk assessment using the Prostate Health Index.PCA3 and PCA3-based nomograms improve diagnostic accuracy in patients undergoing first prostate biopsy.Accuracy of the prostate health index versus the urinary prostate cancer antigen 3 score to predict overall and significant prostate cancer at initial biopsy

P2860

Q26824913-4B4C5DCD-2B47-4FC0-8F90-D598616C5C91 Q26996461-6A3270CB-9BEC-4B16-A7B1-091561050294 Q28071872-7D1D9BCA-4A8F-4269-BBFF-DF917937835F Q30938412-EE1424FA-3981-4FB1-86F1-91E19E4C0160 Q33922390-1E0949A3-8C3C-4041-A999-E9DE3A3A2EA0 Q34371057-8261CC80-CF6C-4F24-BB89-3CAD6707786D Q34825819-9C9A67AE-61A1-4A2C-B181-7A05B2249DF1 Q35921555-6682F26B-E69F-4B39-93BB-9BA204CCA6D7 Q36260364-E5116247-54BD-47CE-B780-6486A5019BB3 Q36886346-03746A1E-4818-4F35-A49D-9E31DBF68C23 Q37113204-A89F353A-B68C-4691-9C6D-CF08DD9385F9 Q37738370-F1C72019-9925-4CE1-B79B-A9C287E3414A Q38090552-DDCBC69D-E0A8-4149-B8FA-8B1A36C337EF Q38211603-C260B1C5-B20B-4F62-811B-9F56602B59DE Q38241107-3B793B4A-7A91-42EF-9705-A5000B2EAB15 Q38379141-2251B38A-7954-4EF3-8B04-059AF5D20107 Q38786630-2DD62E0E-4D65-43F5-AFBB-B198CACEC999 Q40211476-22807537-C3AD-4F27-AC6B-FC760E5B364B Q40270088-108CFAED-340A-42EB-98AC-0DB272ABDA75 Q42663818-5FECE8E8-0350-4471-B8F3-B4FBF41970E1 Q57565075-FA01CC7A-C879-49E0-8B09-43515B079AF7

P2860

Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsy.

http://www.wikidata.org/entity/Q46632925

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Prostate health index (phi) an ...... ts undergoing prostate biopsy.

@en

Prostate health index

@nl

type

label

Prostate health index (phi) an ...... ts undergoing prostate biopsy.

@en

Prostate health index

@nl

prefLabel

Prostate health index (phi) an ...... ts undergoing prostate biopsy.

@en

Prostate health index

@nl

P1433

Q46632925-782A0BD9-C666-40F0-9413-E072F032BA57

P1476

Q46632925-29BA8C1A-5C12-4744-BB36-E3B4BFA1FC65

P2093

Q46632925-052CEF97-0363-4588-97C8-01C862C8C48C

Q46632925-18FBC84D-7F85-4B8D-A1C8-7D5A8372A484

Q46632925-1AB4D651-6BFC-4B27-86A4-B4D1F939CE21

Q46632925-2DB6FBCD-FCF6-4CBC-8F4B-82776305AB45

Q46632925-36AAEB70-E887-44A0-B381-D4B22A4B46C5

Q46632925-46B13641-8991-4470-948A-0B59A6F182C3

Q46632925-4AC24D10-9925-44FC-82EA-69FE1BC1F6A2

Q46632925-5279003D-1733-4B95-9663-9ED8EAC81CB0

Q46632925-7CAB012D-E9BF-4E9A-B2CD-C03B851C8C14

Q46632925-94D08A16-338B-48EF-BA57-831952DD68BB

P2860

Q46632925-1342A277-1A74-44AD-AB42-22488A0282A1

Q46632925-190F6FB7-5196-4BF6-BD20-58F07015F9BF

Q46632925-43391FA6-60DF-4E1E-91C3-0A304384001C

Q46632925-4A6819C4-4AFA-457E-8F51-0D7532E58968

Q46632925-64224D18-6D8C-4D16-8FAE-B67356269E78

Q46632925-64C53E2C-4131-4D25-B13C-FBF5F755DEF8

Q46632925-67B0BB9B-06A8-411C-9D97-752EEFE61174

Q46632925-85A14C5C-AADA-470D-8C77-9A8936852D1F

Q46632925-8A44A603-5B92-449B-AC18-5FAE59A6AEBA

Q46632925-8D000E00-9BD2-4044-97DC-17827A4CCDA3

P304

Q46632925-9851968E-11DA-4B94-9C62-EB4EA9DE1CBE

P31

Q46632925-EA3A5370-60DC-4DF3-BAFE-224656A1D8F2

P356

Q46632925-1195A725-8475-4A3C-89A6-7FDB2E9086C5

P433

Q46632925-01791111-4BAF-46DE-8ABC-C6E76512A6BB

P478

Q46632925-E1A4A5B8-364B-45E3-87D4-AE311336C6B4

P50

Q46632925-00C42543-BA75-4A6D-8151-01369B0E1986

Q46632925-09BB70AC-F534-4D75-8E40-2E5F86C2C36B

Q46632925-1BF0091E-A812-4E74-BAC0-81E60BA4B87D

P577

Q46632925-776C2D72-CD9A-4F2E-B575-2AEEF2CCD7EC

P5875

Q46632925-C15BADE9-0970-4A1D-AD0C-5EF0F0A0540A

P698

Q46632925-7F4C6B2E-FF4F-4066-A8CE-C4E89B761438

P356

P1433

P1476

Prostate health index (phi) an ...... ts undergoing prostate biopsy.

@en

P2093

Ada Marino

http://www.w3.org/2001/XMLSchema#string

Andrea Oliva

http://www.w3.org/2001/XMLSchema#string

Claudia Mazzarella

http://www.w3.org/2001/XMLSchema#string

Daniela Terracciano

http://www.w3.org/2001/XMLSchema#string

Giuseppe Di Lorenzo

http://www.w3.org/2001/XMLSchema#string

Giuseppe Perruolo

http://www.w3.org/2001/XMLSchema#string

Marco De Sio

http://www.w3.org/2001/XMLSchema#string

Michele Longo

http://www.w3.org/2001/XMLSchema#string

Rocco Damiano

http://www.w3.org/2001/XMLSchema#string

Rosa Spinelli

http://www.w3.org/2001/XMLSchema#string

P2860

A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer screening, France

PCA3: from basic molecular science to the clinical lab.

Decision curve analysis: a novel method for evaluating prediction models

Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy.

ProPSA and diagnostic biopsy tissue DNA content combination improves accuracy to predict need for prostate cancer treatment among men enrolled in an active surveillance program.

Tumor markers in prostate cancer I: blood-based markers.

Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group.

Pro-prostate-specific antigen measurements in serum and tissue are associated with treatment necessity among men enrolled in expectant management for prostate cancer.

Urine biomarkers in prostate cancer.

Contemporary role of prostate cancer gene 3 in the management of prostate cancer.

P304

227-235

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PROS.22561

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P50

Riccardo Autorino

P577

2012-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229437715

http://www.w3.org/2001/XMLSchema#string

P698

22821756

http://www.w3.org/2001/XMLSchema#string